Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ex Vivo Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized Medicine

Preprints.org(2023)10.20944/preprints202306.1176.v1Source: DataRank Database

Ex Vivo Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized Medicine is a research paper published in Preprints.org (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (23)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

M. K. Williams,Ryan A. Williams ORCID,Meizhen Chen,Samaneh Kamali ORCID,Vaishnavi Sambandam ORCID

Live enrichment

PubMed:21097893 OpenAlex:https://openalex.org/W4381124535

National Institutes of Health

Grant: 1R21CA264353-01

scDECO: A novel statistical framework to identify differential co-expression gene combinations systematically using single-cell RNA sequencing data

National Institutes of Health

Grant: 5KL2TR002646-03

Institutional Career Development Core (KL2)

National Institutes of Health

Grant: 5KL2TR001118-02

Institute for Integration of Medicine & Science: A Partnership to Improve Health

National Institutes of Health

Grant: 5U54CA217297-02

Systems Analysis of Epigenomic Architecture in Cancer Progression

greenLicense: cc-by

repositoryhttps://www.preprints.org/frontend/manuscript/dde66fe8c1de588ee59a60c796c771d6/download_pub

repositoryhttp://dx.doi.org/10.20944/preprints202306.1176.v1

https://doi.org/10.20944/preprints202306.1176.v1

Fields of Study

Cancer Cells and MetastasisCancer Genomics and Diagnostics3D Printing in Biomedical Research03 medical and health sciences0302 clinical medicine

Keywords

Ex vivoLung cancerMedicinePersonalized medicineTargeted therapyPrecision medicineDrugCancerOncologyLiquid biopsyCompanion diagnosticInternal medicineIn vivoCancer researchPharmacologyPathologyBioinformaticsBiology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being